SPONSOR
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Total Trials
9
Recruiting
9
Phases
N/A
Conditions studied: EpilepsyAneurysmsArteriovenous MalformationsCavernomasSkull Base TumorsMoyamoya DiseaseDural FistulasSubdural HematomaExtradural HematomaSubarachnoid Hemorrhage
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta is a clinical research sponsor with 9 registered studies on ClinicalTrials.gov, of which 9 are actively recruiting participants. Research covers conditions including Epilepsy, Aneurysms, Arteriovenous Malformations, Cavernomas.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
How many clinical trials has Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta sponsored?
ClinicalMetric currently tracks 9 clinical trials sponsored by Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, of which 9 are actively recruiting participants. These trials cover conditions including Epilepsy, Aneurysms, Arteriovenous Malformations. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta research focus on?
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta clinical trials span Epilepsy, Aneurysms, Arteriovenous Malformations, Cavernomas, Skull Base Tumors, and additional conditions. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta clinical trial?
To participate in a Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta trials with current recruitment status updated daily.
Clinical Trials by Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
NCT06794606
Recruiting
Study for the Diagnosis and Treatment of Drug-resistant Focal Epilepsies
Epilepsy
NCT06724029
Recruiting
Neurosurgical Outcome Network
Aneurysms
NCT07233941
Recruiting
Neuropsychological Profile Characterization in Patients With Migraine: Cognitive Functioning and Psychological Variables
Migraine
NCT07420543
Recruiting
Clinical Significance of Liquid Biopsy in Brain Tumor Patients: a 5-ALA Guided Approach
Brain Tumors and/or Solid Tumors Including
NCT06935578
Recruiting
RAre, But Not aLone: a Large Italian Network to Empower the Impervious diaGNostic Pathway of Rare cerEbrovascular Diseases (ALIGNED)
CADASIL
NCT07123233
Recruiting
An Innovative Cognitive-Behavioral Treatment For Chronic Orofacial Pain
Chronic Primary Orofacial Pain (CPOP)
NCT04204642
Recruiting
SEarchiNg biomarkErs Cerebral Amyloid Angiopathy (SENECA)
Cerebral Amyloid Angiopathy
NCT06938100
Recruiting
Genotype, Clinical Features and Imaging of Neuroradiological Abnormalities in CADASIL
CADASIL
NCT06938178
Recruiting
High-Density EEG-MEG-wearable EEG: Comparison of Quantitative Electroencephalographic Indicators as Neurophysiological Markers of Effectiveness of Mindfulness Therapy in Addition to Standard Treatment in Patients With High-frequency Episodic Migraine
Migraine
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology